Albireo Pharma Valuation

ALBODelisted Stock  USD 44.15  0.75  1.67%   
At this time, the firm appears to be overvalued. Albireo Pharma shows a prevailing Real Value of $32.14 per share. The current price of the firm is $44.15. Our model approximates the value of Albireo Pharma from analyzing the firm fundamentals such as profit margin of (2.29) %, and Return On Equity of -0.93 as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Albireo Pharma Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Albireo Pharma's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today
44.15
Please note that Albireo Pharma's price fluctuation is very steady at this time. Calculation of the real value of Albireo Pharma is based on 3 months time horizon. Increasing Albireo Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Albireo Pharma is useful when determining the fair value of the Albireo stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Albireo Pharma. Since Albireo Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Albireo Stock. However, Albireo Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  44.15 Real  32.14 Hype  44.15
The real value of a stock, also known as the intrinsic value, is the underlying worth of a company that is reflected in its stock price. It is based on the company's financial performance, assets, liabilities, growth prospects, management team, industry conditions, and other relevant factors. The real value of a stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, price-to-book ratio, and other valuation metrics. The real value of a stock may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence the stock's price. It is important to note that the real value of a stock is not a fixed number and may change over time based on changes in the company's performance and other relevant factors.
32.14
Real Value
48.57
Upside
Estimating the potential upside or downside of Albireo Pharma helps investors to forecast how Albireo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Albireo Pharma more accurately as focusing exclusively on Albireo Pharma's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
44.1544.1544.15
Details

Albireo Pharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Albireo Pharma's current stock value. Our valuation model uses many indicators to compare Albireo Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Albireo Pharma competition to find correlations between indicators driving Albireo Pharma's intrinsic value. More Info.
Albireo Pharma is number one stock in price to sales category among related companies. It is number one stock in price to earning category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Albireo Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Albireo Pharma's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Albireo Pharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Albireo Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Albireo Pharma and how it compares across the competition.

About Albireo Pharma Valuation

The delisted stock valuation mechanism determines the current worth of Albireo Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Albireo Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Albireo Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Albireo Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Albireo Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Albireo Pharma. We calculate exposure to Albireo Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Albireo Pharma's related companies.
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts. Albireo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 130 people.

8 Steps to conduct Albireo Pharma's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Albireo Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Albireo Pharma's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Albireo Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Albireo Pharma's revenue streams: Identify Albireo Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Albireo Pharma's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Albireo Pharma's growth potential: Evaluate Albireo Pharma's management, business model, and growth potential.
  • Determine Albireo Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Albireo Pharma's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Albireo Pharma Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Albireo Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding19.2 M
Retained Earnings-300.9 M
Retained Earnings Total Equity-300.9 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk